BRIP1 and esophageal squamous cell carcinoma: ESCC patients with the BRIP1 mutant also displayed worse outcomes than ones with the BRIP1 wild type, achieving an mPFS of 5.87 months and an mOS of 11.38 months (Figures 2C,D).